Federal Register Notice: CDER will hold a scientific public workshop 2/11-12/13 to solicit information on a variety of issues related to the clinical development of disease-modifying agents for treating peripheral neuropathy. Discussion will focus on possible therapeutic targets for these agents, the types of painful peripheral neuropathies amenable to treatment with disease-modifying agents, and clinical trial design. The workshop will be held 2/11, from 8:30 a.m. to 5 p.m. and 2/12, from 8:30 a.m. to 2 p.m. at FDA White Oak Campus, Building 31, The Great Room (Rm. 1503), White Oak Conference Center, 10903 New Hampshire Ave., Silver Spring, MD. Contact Randi Clark or Allison Meyer, (301) 796-1258. To view this notice, click here.